Difficulties faced by clinicians in routine clinical practice when selecting the appropriate treatment for patients with actinic keratosis (AK) include: the independent evaluation of AK lesions, the absence of a standardized definition of field cancerization (FC), and the lack of a reproducible classification to grade the entire AK-affected area. Moreover, to assess the severity of AK, most guidelines rely on lesion count, which is often not reproducible among specialists. The present work has 2 main objectives: first, to review and highlight some of the issues clinicians tackle when classifying and monitoring AK lesions and the status of FC, looking in more detail at some of the most commonly used clinical scales for classifying AK lesions. Second, we pose questions that we encounter in daily clinical practice, and whose answers or comments help to deal with cases of AK, facilitating the work of clinicians: How should we approach AK diagnosis? How do the challenges of clinical studies on the evaluation of treatment efficacy translate into clinical practice? We review the literature on the clinical classifications and management of AK, and propose how to guide the diagnosis, management, Penalties and monitoring Apply of patients with AK.
CITATION STYLE
Schmitz, L., Broganelli, P., & Boada, A. (2022, August 1). Classifying Actinic Keratosis: What the Reality of Everyday Clinical Practice Shows Us. Journal of Drugs in Dermatology. Journal of Drugs in Dermatology. https://doi.org/10.36849/JDD.6704
Mendeley helps you to discover research relevant for your work.